Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shun Lu

Showing results (301-310 of 704) with videos related to

Pageof 71
Sort By:
BMC Pulmonary Medicine|August 2, 2025
Amivantamab versus standard therapies among patients with advanced non-small cell lung cancer and epidermal growth factor receptor exon 20 insertion mutations after platinum-based therapy in ChinaLan Shen, Guangyuan Hu, Yan Wang, et al.
Gene|August 17, 2014
Molecular cloning, characterization and tissue distribution of two ostrich β-defensins: AvBD2 and AvBD7Shun Lu, Kemei Peng, Qishuang Gao, et al.
American Journal of Translational Research|February 17, 2021
A multi-omics-based serial deep learning approach to predict clinical outcomes of single-agent anti-PD-1/PD-L1 immunotherapy in advanced stage non-small-cell lung cancerYi Yang, Jiancheng Yang, Lan Shen, et al.
Cancer Management and Research|August 3, 2019
Intercalated combination of chemotherapy and erlotinib for stage IIIA non-small-cell lung cancer: a multicenter, open-label, single-arm, phase II studyZhiwei Chen, Shengping Shen, Wenbo Shi, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 28, 2012
Establishment of a biomarker model for predicting bone metastasis in resected stage III non-small cell lung cancerZhen Zhou, Zhi-Wei Chen, Xiao-Hua Yang, et al.
Cell Biology and Toxicology|June 17, 2025
Single-cell spatial proteomics of non-relapse small cell lung cancer identifies tumor microenvironment determinants of survivalYin Li, Liliang Xia, Hui Wang, et al.
Cancer Letters|May 15, 2018
Corrigendum to "The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer" [Canc. Lett. 423 (2018) 36-46]Tingting Lu, Ziming Li, Ying Yang, et al.
Hypertension (Dallas, Tex. : 1979)|August 12, 2009
Phosphate-activated glutaminase-containing neurons in the rat paraventricular nucleus express angiotensin type 1 receptorsNan Jiang, Peng Shi, Hongwei Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 31, 2011
[Short-term intermittent prophylactic administration of recombinant human thrombopoietin attenuates chemotherapy-induced thrombocytopenia in lung cancer patients]Yun-hua Xu, Bai-jun Cheng, Shun Lu, et al.
Oncology Reports|December 18, 2015
FAM172A modulates apoptosis and proliferation of colon cancer cells via STAT1 binding to its promoterKai Qian, Jinqian Zhang, Jingbo Lu, et al.
Pageof 71

Showing results (301-310 of 704) with videos related to

Sort By:
Pageof 71
BMC Pulmonary Medicine|August 2, 2025
Amivantamab versus standard therapies among patients with advanced non-small cell lung cancer and epidermal growth factor receptor exon 20 insertion mutations after platinum-based therapy in ChinaLan Shen, Guangyuan Hu, Yan Wang, et al.
Gene|August 17, 2014
Molecular cloning, characterization and tissue distribution of two ostrich β-defensins: AvBD2 and AvBD7Shun Lu, Kemei Peng, Qishuang Gao, et al.
American Journal of Translational Research|February 17, 2021
A multi-omics-based serial deep learning approach to predict clinical outcomes of single-agent anti-PD-1/PD-L1 immunotherapy in advanced stage non-small-cell lung cancerYi Yang, Jiancheng Yang, Lan Shen, et al.
Cancer Management and Research|August 3, 2019
Intercalated combination of chemotherapy and erlotinib for stage IIIA non-small-cell lung cancer: a multicenter, open-label, single-arm, phase II studyZhiwei Chen, Shengping Shen, Wenbo Shi, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 28, 2012
Establishment of a biomarker model for predicting bone metastasis in resected stage III non-small cell lung cancerZhen Zhou, Zhi-Wei Chen, Xiao-Hua Yang, et al.
Cell Biology and Toxicology|June 17, 2025
Single-cell spatial proteomics of non-relapse small cell lung cancer identifies tumor microenvironment determinants of survivalYin Li, Liliang Xia, Hui Wang, et al.
Cancer Letters|May 15, 2018
Corrigendum to "The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer" [Canc. Lett. 423 (2018) 36-46]Tingting Lu, Ziming Li, Ying Yang, et al.
Hypertension (Dallas, Tex. : 1979)|August 12, 2009
Phosphate-activated glutaminase-containing neurons in the rat paraventricular nucleus express angiotensin type 1 receptorsNan Jiang, Peng Shi, Hongwei Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 31, 2011
[Short-term intermittent prophylactic administration of recombinant human thrombopoietin attenuates chemotherapy-induced thrombocytopenia in lung cancer patients]Yun-hua Xu, Bai-jun Cheng, Shun Lu, et al.
Oncology Reports|December 18, 2015
FAM172A modulates apoptosis and proliferation of colon cancer cells via STAT1 binding to its promoterKai Qian, Jinqian Zhang, Jingbo Lu, et al.
Pageof 71